Evidence map›Paper›PMID 41155699›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Anti-

Mario Alberto Hernández-Torres, Sara García-Davis, José J Fernández, Ana R Diaz-Marrero, Magda Elizabeth Hernández-García, Irma Edith Carranza-Torres, Ezequiel Viveros-Valdez

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario Alberto Hernández-TorresDepartamento de Química, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Avda. Pedro de Alba S/N, San Nicolás de los Garza 66450, Nuevo León, Mexico.ORCID 0000-0002-2017-9605
Sara García-DavisInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Spain.ORCID 0000-0003-1487-4959
José J FernándezInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Spain.ORCID 0000-0002-0805-8317
Ana R Diaz-MarreroBiotecnología Marina, Unidad Asociada al IPNA-CSIC por el IUBO-ULL, 38206 La Laguna, Spain.ORCID 0000-0002-8886-7519
Magda Elizabeth Hernández-GarcíaInstituto Mexicano del Seguro Social, Centro de Investigación Biomédicas del Noreste, 2 de Abril # 501, Monterrey 64720, Nuevo León, Mexico.
Irma Edith Carranza-TorresDepartamento de Química, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Avda. Pedro de Alba S/N, San Nicolás de los Garza 66450, Nuevo León, Mexico.
Ezequiel Viveros-ValdezDepartamento de Química, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Avda. Pedro de Alba S/N, San Nicolás de los Garza 66450, Nuevo León, Mexico.ORCID 0000-0001-5944-7972

Funding

ProID2024010033 PROMOTUR_SP3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-trichomonal activitybetulinmolecular dockingstigmasterolTagetes nelsoniitriterpenes

Identifiers

PMID41155699
PMCPMC12566863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.